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Abstract
Due to the large number of putative microRNA gene targets predicted by sequence-alignment databases and the relative
low accuracy of such predictions which are conducted independently of biological context by design, systematic
experimental identification and validation of every functional microRNA target is currently challenging. Consequently,
biological studies have yet to identify, on a genome scale, key regulatory networks perturbed by altered microRNA
functions in the context of cancer. In this report, we demonstrate for the first time how phenotypic knowledge of
inheritable cancer traits and of risk factor loci can be utilized jointly with gene expression analysis to efficiently prioritize
deregulated microRNAs for biological characterization. Using this approach we characterize miR-204 as a tumor suppressor
microRNA and uncover previously unknown connections between microRNA regulation, network topology, and expression
dynamics. Specifically, we validate 18 gene targets of miR-204 that show elevated mRNA expression and are enriched in
biological processes associated with tumor progression in squamous cell carcinoma of the head and neck (HNSCC). We
further demonstrate the enrichment of bottleneckness, a key molecular network topology, among miR-204 gene targets.
Restoration of miR-204 function in HNSCC cell lines inhibits the expression of its functionally related gene targets, leads to
the reduced adhesion, migration and invasion in vitro and attenuates experimental lung metastasis in vivo. As importantly,
our investigation also provides experimental evidence linking the function of microRNAs that are located in the cancer-
associated genomic regions (CAGRs) to the observed predisposition to human cancers. Specifically, we show miR-204 may
serve as a tumor suppressor gene at the 9q21.1–22.3 CAGR locus, a well established risk factor locus in head and neck
cancers for which tumor suppressor genes have not been identified. This new strategy that integrates expression profiling,
genetics and novel computational biology approaches provides for improved efficiency in characterization and modeling of
microRNA functions in cancer as compared to the state of art and is applicable to the investigation of microRNA functions in
other biological processes and diseases.
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Introduction
Since the discovery of microRNAs as important regulators of
broad biological processes [1–5], characterization of their
functions in cancer has been hindered by lack of microRNA
profiling information in tumors such as squamous cell
carcinoma of the head and neck (HNSCC). Previous reports
show that only one or a few gene targets, identified among
predicted or differentially expressed genes, were directly
targeted by the microRNA under investigation [6–8]. While
sequence-based computational algorithms have been applied
for predicting all potential microRNA gene targets; false
positive rates remains relatively high [9,10]. Further, se-
quence-based predictions are unable, by design, to account
for biological contexts (e.g. cell and tissue types, normal or
disease conditions) and thus are not optimized for predicting the
biological function of genes targeted by cancer microRNAs.
Moreover, genome-scale and biological studies have yet to
identify key regulatory networks perturbed by altered micro-
RNA functions in cancer.
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develop an effective computational approach that is complemen-
tary to microRNA profiling and, in addition, is capable of
simultaneously predicting tumor suppressor microRNAs as well as
their functional targets from gene expression. In this report we
illustrate how phenotypic knowledge of genetic disorders (OMIM
database) can be utilized jointly with gene expression analyses to
achieve this goal. Using this approach, we selected miR-204
among ten prioritized microRNAs for biological characterization,
as miR-204 is located at the cancer-associated genomic region
(CAGR) 9q21.1–q22.3 locus exhibiting high frequency of Loss of
heterozygosity (LOH) in human HNSCC [11–15], and a CAGR
for which candidate tumor suppressor gene targets have not been
identified. Additionally, we report the first computationally
predicted and biologically validated microRNA-regulated network
that is dependent on the epidermal growth factor receptor (EGFR)
whose overexpression occurs in over 80% of head and neck
cancer. We further demonstrate that gene targets of miR-204
exhibit enriched bottleneck and hub network topology properties
in a predicted protein-protein interaction network (PPIN).
Moreover, we confirm the validity of our computational
predictions of a microRNA function, as well as its gene targets
and system’s properties through conducting extensive and
thorough biological characterization using a clinically relevant in
vivo metastatic model of head and neck cancer.
In summary, we show how such a high throughput system’s
strategy can accelerate the investigation of microRNA function in
cancer by illustrating altered complex biological processes and
regulatory pathways associated with microRNA dysfunction in
cancer, by identifying among all putative microRNA gene targets
only those that are dysregulated, and by elucidating molecular
interactions underpinning microRNA regulation of malignant
transformation and progression. The ability to characterize tumor
suppressor microRNAs through a network analysis of mRNA
expression datasets would be a major advance with potentially
wide application. Further, we provide experimental evidence
linking microRNA function to the genetic risk of HNSCC. We
show at the LOH 9q21.1–22.3 locus, miR-204 could serve as a
tumor suppressor of HNSCC oncogenesis and progression.
Results
A figure summarizing the main results and experimental
approaches of this paper is included as Supporting Figure 1 in
Text S1.
Combining genome-scale predictive strategies to
prioritize candidate microRNAs for biological
characterization in HNSCC
At the time of initiating this study, comprehensive analysis of
microRNA expression profile in head and neck cancer (HNSCC)
was not available and would have required time-consuming
accruement of tumor tissues for conducting such analysis, a
situation that is not limited to HNSCC research. We hypothesized
that the development of a computational capability to simulta-
neously predict tumor suppressor microRNAs as well as their
functional targets from more widely available genome-wide gene
expression datasets could be an efficient reverse engineering
approach for identifying deregulated microRNAs and their
functional gene targets.
We first developed IMRE, a statistical method to predict altered
expression of microRNAs from genome-wide mRNA expression
and putative microRNA targets databases (Supporting Figure 2 in
Text S1, Materials and Methods). This strategy is based, in part,
on the observations that at genome scale the expression of
microRNAs and their direct mRNA targets are, in general,
inversely correlated [16,17]. To conduct this analysis, we
integrated five complementary microRNA target databases to
generate ‘‘miRNOME’’ that contains 534 human microRNAs and
17,343 microRNA gene targets (Materials and Methods, and
Table 1 in Text S2). We validated this method using two
independent cancer expression profiling experiments in GEO
comprised of paired mRNA and microRNA expressions for
tumors and normal tissue (GSE2564 [18]: multiple epithelial
cancer; GSE8126 [19]: prostate cancer). IMRE-predicted down-
regulated microRNAs that are exclusively inferred from mRNA
expression and microRNA targets datasets (Materials and
Methods) were enriched in the expression analysis of the
corresponding microRNA array dataset (GSE2564: P=0.014;
GSE8126: P=0.0002 respectively, cumulative hypergeometric
test, data not shown). A recent study also demonstrated the
increased prediction specificity of microRNA and its gene target
relationship via intersecting the results of multiple prediction
algorithms [20].
Subsequently, we applied the IMRE method to analyze two
independent HNSCC mRNA microarray datasets for predicting
deregulated microRNAs from genome-wide mRNA expression
(Supporting Figure 2 in Text S1, Materials and Methods): first, the
GSE6631 set that provides differential mRNA gene expression
between 22 HNSCC non-microdissected patient tumor samples
and their paired normal squamous tissues [21], and second, the
GSE2379 [22] set that contains 34 micro-dissected node-positive
HNSCC tumors of the hypopharynx. We noted that vast majority
of the known microRNAs had at least one putative target in the
top 500 deregulated genes of the HNSCC expression arrays
(GSE6631), with a median of 19 targets. Therefore, it is unfeasible
to manually select microRNA candidates from their deregulated
targets for biological validation. Applying IMRE method to each
dataset, we predicted a set of down-regulated microRNAs in
HNSCC (113 and 43, respectively; FDR #0.05, Materials and
Methods), of which 34 were consistently found in both prediction
Author Summary
MicroRNAs regulate the expression of genes in cells and
are important in cancer development and progression.
Designing new microRNA-based treatments requires the
understanding of their mechanisms of action. Previous
biological studies lack in depth since only a few genes are
confirmed as microRNA targets. Additionally, key biological
systems perturbed by altered microRNA functions in the
context of cancer remain to be identified. Here, we
demonstrate for the first time how genetic knowledge
about the inheritance of cancer can be utilized jointly with
data about the expression of genes in cancer samples to
model deregulated microRNAs and their functions at
multiple scales of biology. Our approach further uncovers
previously unknown connections between microRNAs,
their regulated genes, and their dynamics. Using head
and neck cancer as a model, we predict the presence,
functions, and gene targets of a new tumor suppressor
microRNA in a cancer-associated chromosomal region
where a candidate gene has not been identified. We then
confirm their validity with extensive and thorough
biological characterization and show attenuation of lung
metastasis in mice. The discovery of molecular networks
regulated by microRNAs could be exploited for the design
of new treatments as an alternative to the single-gene
target paradigm.
Network Modeling of microRNA Function in Cancer
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216, Fisher’s exact test, Figure 1A and Table
2 in Text S2, FDR ,0.05, Materials and Methods). Predictions of
up-regulated microRNAs did not reach reproducible statistical
significance (not shown).
To further reduce the number of microRNAs to the most
promising candidates for HNSCC, we conducted a statistical
enrichment analysis of putative microRNA targets among
inheritable cancer genes in the OMIM human disease gene
database [Online Mendelian Inheritance in Man, http://www.
ncbi.nlm.nih.gov/omim/ (downloaded Dec. 1, 2006)]. OMIM
contains 610 biologically validated cancer genes among which 586
(96%) are predicted targets of 527 microRNAs in miRNOME. We
observed that each of the 527 microRNAs could, on average,
target 30 OMIM cancer genes (not shown). Thus, it is also
unfeasible to manually select microRNA candidates from OMIM
cancer genes for biological validation. Our analyses identified 46
microRNAs significantly enriched in the inheritable cancer gene
subset of OMIM in the miRNOME (Figure 1A; Table 3 in Text
S2, Materials and Methods, Protocol S1/Section A, and Dataset
S1). Since microRNAs can be deregulated across cancers of
different tissue origin [23], we performed a review of literature and
confirmed the validity of these 46 predictions (OMIM; Supporting
Figure 3 in Text S1, P=0.039; cumulative hypergeometric test,
Table 4 in Text S2, Materials and Methods).
Thereafter, we reduced the list of candidates in HNSCC to ten
microRNAs (Figure 1A) that were predicted in the HNSCC gene
expression (34 microRNAs; Table 2 in Text S2) as well as in
inheritable cancer genes (46 microRNAs; Table 3 in Text S2).
Among the ten prioritized microRNAs, four belong to the let-7
tumor suppressor microRNA family (Figure 1A).
miR-204 is located at the genomic imbalanced 9q21.1-
22.3 locus associated with genetic predisposition for
head and neck cancer
We chose miR-204 among the ten prioritized microRNAs for
thorough biological characterization based on the following
considerations. First, miR-204 is located within the sixth intron
of the host gene transient receptor potential melastatin 3 cation
channel (TRPM3, NM_020952) and is transcribed in the same
direction as TRPM3 [24]. TRPM3 is located on human
chromosome 9q21.11 that is within the 9q21.1–q22.3 locus
exhibiting high frequency of Loss of heterozygosity (LOH) in
human HNSCC [11–15]. LOH at 9q21.1–q22.3 occurs in 37% of
premalignant head and neck lesions, and increases to 67% in
HNSCC [14]. Second, in addition to the genomic imbalance at
9q21.1–q22.3 locus, chromosomal aberrations occur most fre-
quently at 3p, 5q, 9p, 11q and 17p in HNSCC [11,12,25]. With
the exception of let-7g that is located at the 3p21 locus (note that
let7g is also included in the class of microRNAs with related
mature sequence ‘‘Let7/98’’), the other 7 prioritized microRNAs
are not in the cancer associated genomic regions (CAGRs). Third,
while potential tumor suppressor gene candidates have been
identified for other CAGRs in HNSCC, gene candidates
possessing tumor suppressor activity associated with the 9q21
locus have not been identified. Thus the mechanisms by which
changes at this locus affecting HNSCC oncogenesis remain
uncharacterized. Fourth, the role of miR-204 in human cancer
has not been established.
We first examined miR-204 host gene TRPM3 expression by
quantitative PCR (qPCR) and observed near complete TRPM3
suppression in four micro-dissected HNSCC tumors (Figure 1B)
and in a panel of 10 low passage HNSCC cell lines generated from
tumors of diverse head and neck locations (Figure 1C and Table 5
in Text S2) [26]. We subsequently measured miR-204 expression
in HNSCC tumors and cell lines. Consistent with the observed
near complete loss of TRPM3 (Figures 1B–C), miR-204
expression was inhibited in all four tumors by 85% to 99%
(Figure 1D), and by more than 90% in all ten HNSCC cell lines
(Figure 1E) compared to samples of pooled normal buccal mucosa.
The frequent allelic loss at 9q21.1–q22.3 in HNSCC [11–14]
provides genetic evidence that loss of miR-204 microRNA
function may occur as a result of genomic imbalance at this site
and that miR-204 may be a potential candidate associated with
the tumor suppressor activity of 9q21.1–q22.3.
Since miR-204 was also predicted in the OMIM analysis to be
associated with lymphoma (Table 3 in Text S2), we quantified
miR-204 expression in immortalized ‘‘normal B cell 11365’’ and
three Burkitt B-cell lymphoma cell lines and found its expression
significantly reduced (Figure 1F). Further, paired comparison of
miR-204 expression between 6 types of adenocarcinomas and
their respective normal tissues was conducted using the microRNA
array dataset GSE2564 [18]. miR-204 was significantly down-
regulated in breast (P=0.014), kidney (P=0.004) and prostate
(P=0.0001) tumors (Figure 1G). Additionally, significant miR-204
down-regulation was recently reported in a subtype of acute
myeloid leukemia bearing cytoplasmic mutated nucleophosmin
[27]. Here, we demonstrate for the first time, the accuracy and
efficiency of joint analyses of mRNA expression, inheritable
disease genes, and microRNA target databases to prioritize
deregulated microRNAs for biological characterization. Collec-
tively, these biological findings support the validity of our
computational predictions of miR-204 downregulation in HNSCC
and suggest that it may possess tumor suppressor activity.
Predicted miR204 gene targets are significantly related
through their biological functions
Among the 1,088 putative miR-204 targets predicted in the
miRNOME, 34 mRNA transcripts that were significantly upregu-
lated in HNSCC (GSE6631) led to the enrichment of miR-204
(Figure 2A and Table 6 in Text S2). We first conducted statistical
functional enrichment analysesusing Gene Ontology(GO) [28] and
foundanumberofbiologicalprocesses(BP)and molecularfunctions
(MF) of GO were significantly enriched among 32 of the 34 miR-
204 gene targets (referred to as ‘‘functionally prioritized miR-204
targets’’) (Table 7 in Text S2, Materials and Methods, and Protocol
S1/Section C). We next examined mRNA expression status of 21
representative ‘‘functionally prioritized miR-204 targets’’ in four
laser capture microdissected HNSCC tumor samples and observed
increased expression of 18 of these genes compared with their
respective expression in five pooled normal buccal mucosa
(Figure 2B). Additionally analysis of thirteen ‘‘functionally priori-
tized miR-204 targets’’, those enriched with the listed GO functions
(the table in Figure 2B, Materials and Methods), showed
overexpression of nine targets in ten HNSCC cell lines
(Figure 2C). These results indicate that predicted miR-204 targets,
upregulated in HNSCC, share similar functions and may
participate in similar biological processes.
miR-204 suppresses the expression of its functionally
prioritized targets
To provide evidence that miR-204 can directly suppress the
expression of its predicted targets in HNSCC, examination of the
39UTR confirmed that all 34 predicted target genes contain at least
one miR-204 binding site as expected by our predictions using
sequence homology databases of the miRNOME (Table 8 in Text
S2, and Materials and Methods). Thereafter, we selected 21
‘‘functionally prioritized miR-204 targets’’ overexpressed in
Network Modeling of microRNA Function in Cancer
PLoS Computational Biology | www.ploscompbiol.org 3 April 2010 | Volume 6 | Issue 4 | e1000730Figure 1. Combining genome-scale predictive strategies to predict and prioritize candidate microRNAs in HNSCC. (A) Enriched gene
targets of 46 microRNAs among inheritable cancer genes in OMIM are significantly overlapping with 34 predictions of deregulated microRNAs based
on HNSCC expression arrays (GSE6631, GSE2379; Figure S3; Table S2 and Table S3), yielding ten prioritized microRNAs (P=2.33610
24). P: Cumulative
hypergeometric Statistics. 1: miR-204 and let-7g are located in chromosomal regions with known increased genetic risk of HNSCC (9q21.1–22.1 for
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miR-204 gain-of-function analyses by transiently transfecting JSQ3
and SQ38 HNSCC cells with mature miR-204 mimics (Dharma-
con) to enhance miR-204 function in these two cell lines.
Restoration of miR-204 function achieved significant inhibition
(between 30% to 75%) of endogenous mRNA expression in 18 out
of 21 predicted targets examined for both cell lines, while non-
specific control mimics had no significant effect (Figure 2D and
Supporting Figures 4–5 in Text S1). The specificity of miR-204
mimics was further confirmed by unaltered expression of four
endogenous housekeeping genes (GUSB, HPRT1, HUPO and
PPIA) that lack target homology to miR-204 (Figure 2D and
Supporting Figure 4 in Text S1). Comparing with sequence-based
microRNA gene target prediction algorithms that have true positive
rates of about 40% [9,10], the accuracy of our prediction methods is
higher (,90%). Collectively, these observations indicate that down-
regulation of functionally related miR-204 targets upon miR-204
mimics treatment was sequence specific and was not due to artifacts
of transfection or the ‘‘off target’’ effect of miR-204 mimics.
miR-204 gene targets exhibit significant topological
properties in a HNSCC protein interaction network
predicted by network modeling
Following functional enrichment analysis of upregulated miR-
204 targets in HNSCC, we next examined the role of miR-204
targets in modulating the function of a protein-protein interaction
network (PPIN). To identify genome-wide changes in PPINs
associated with altered microRNA functions in HNSCC, we first
integrated seven protein-protein interaction databases (Materials
and Methods) and generated a ‘‘genome-scale PPIN’’ that contains
44,695 protein-protein interactions and 7,321 predicted human
genes targets for the 532 microRNAs in the miRNOME. We
subsequently could map 260 out of 382 (68%) up-regulated genes
in GSE6631 to the PPIN (refer to as ‘‘HNSCC PPIN’’), of which
24 were miR-204 targets predicted in miRNOME. We next
computed the empirical probability of interactions among these
260 genes in the network using permutation resampling (Materials
and Methods). To identify the most important interactions in the
HNSCC PPIN, we retained proteins for which the number of
observed interactions was significantly increased in single protein
network modeling as compared to those found in the empirical
distribution (Materials and Methods). As a result, we identified a
protein regulatory network in HNSCC consisting of 56 prioritized
upregulated genes in GSE6631 at a low false discovery rate of 7%
(Figure 3 and, Materials and Methods) (referred to as ‘‘prioritized
HNSCC PPIN’’). Among the 24 miR-204 targets mapped to the
genome-scale PPIN, seven were present in the ‘‘prioritized
HNSCC PPIN’’ (Figure 3, shown in red). Further, six of the
seven-miR-204 targets remained prioritized when computed using
different network modeling conditions demonstrating the robust-
ness of our analyses (not shown, and Materials and Methods).
We next analyzed two topological features of the PPIN: the
‘‘hub’’ and ‘‘bottleneck’’ properties. ‘‘Hubs’’, the highly connected
node proteins, and ‘‘bottlenecks’’, the key connector proteins, are
central to controlling the connectivity of biological sub-networks to
one another [29]. Further, our prior studies showed proteins
possessing both properties (hub-bottleneck) as essential and
efficient network components to alter the functional output of a
PPIN upon their dynamic changes in gene expression [30]. Here,
we observed significant enrichment of hubs, bottlenecks, and hub-
bottleneck proteins in the 56-gene ‘‘prioritized HNSCC PPIN’’ as
compared to either the ‘‘genome-scale PPIN’’ or to the ‘‘HNSCC
PPIN’’ (hub: P=8.7610
28; bottleneck: P=7.31610
27; hub-
bottleneck: P=1.61610
28; Materials and Methods). Additionally,
the proportion of hub-bottleneck genes was further enriched
among the seven miR-204 targets present in the ‘‘prioritized
HNSCC PPIN’’ (P=0.002; Fisher’s exact test, MMP9, SHC1,
CDC25B and AURKB in Figures 3A–B). Moreover, in a genome-
scale analysis, we observed a statistically significant association
between the proteins that exhibit PPIN network topology, such as
hub and bottleneck properties, and the number of predicted
microRNA targets. Indeed, bottleneck proteins and hub-bottle-
neck protein of the ‘‘genome-scale PPIN’’ were both targeted on
average by more microRNAs than those that are neither
bottleneck nor hub-bottleneck (bottleneck: P=0.0009; hub-
bottleneck: P=0.022, Materials and Methods). These results
indicate that the enrichment of bottleneck and hub-bottleneck
properties among miR-204 gene targets in the ‘‘prioritized
HNSCC PPIN’’ is a system’s property of microRNAs. They also
suggest that the efficiency and specificity of microRNAs in
regulating biological functions is further strengthened through
alteration of the translation of these bottleneck proteins.
In a protein-protein interaction network, proteins that are
tightly linked are likely to function in the same biological process
or pathways [31,32]. To characterize functional relationships
among the 56 interacting proteins in the ‘‘prioritized HNSCC
PPIN’’, we conducted statistical enrichment analysis using Gene
Ontology (Materials and Methods, Protocol S1/Section C). The
biological processes (BP) and molecular functions (MF) enriched in
this network (Figure 3C, Materials and Methods) overlapped with
our findings of functional enrichment among 34 predicted miR-
204 targets (Figures 2B–C). Two EGFR-dependent regulatory
sub-networks were identified: cell cycle regulation and extracellu-
lar matrix (ECM) remodeling/Cell-matrix adhesion (Figure 3C).
Based on the importance of hub-bottleneck genes in regulating the
function of a PPIN [33], the enrichment of four hub-bottlenecks
miR-204 targets in the EGFR-dependent ‘‘prioritized HNSCC
PPIN’’ predicts that their up-regulation upon miR-204 suppres-
sion in HNSCC could significantly augment cell cycle and
extracellular matrix remodeling.
miR-204 suppressed HNSCC cell migration, adhesion and
invasion in vitro and lung colonization in vivo
Among miR-204 gene targets that are potential regulators of
cell-matrix interaction and proteolysis, overexpression of APRC1B
[34], CTSC [35], FAP [36], MMPs [37], BMP1 [38], CDH11
miR-204 and 3p21 for let-7g, respectively) [15]. (B–C) mRNA expression of TRPM3, the host gene of miR-204, is significantly downregulated and is
barely detectable in four microdissected head and neck tumors (B) and in a panel of ten low passage HNSCC cell lines [26] (C). TRPM3 mRNA
expression was determined by qRT-PCR and normalized with the TBP endogenous gene control. Triplicate real time PCR measurements were
obtained and the mean Ct (cycle threshold) was used to calculate RQ values. Standard deviation of the triplicate measurement was less than 0.15 Ct.
Shown are relative tumor TRPM3 mRNA expression levels compared with five pooled normal buccal mucosa. (D–F) Quantification of miR-204
expression by Taqman qPCR in four laser micro-captured head and neck tumors (D), in ten HNSCC cell lines (E) and in three Burkitt’s B-cell lymphoma
cell lines (F). Five equally pooled normal buccal mucosa RNAs were used as the normal control for HNSCC tumors and cell lines. Normal B cell RNA
was used as the normal control for Burkitt’s B-cell lymphoma. (G) Comparison of miR-204 expression between six types of human epithelial cancers
tissues and their respective normal tissues was conducted using the microRNA profiling dataset GSE2564 [18] (P-values were calculated using two-tail
unpaired t-test; ‘‘n’’ indicates number of patients; error bars represent mean 6 standard error of the mean, Materials and Methods).
doi:10.1371/journal.pcbi.1000730.g001
Network Modeling of microRNA Function in Cancer
PLoS Computational Biology | www.ploscompbiol.org 5 April 2010 | Volume 6 | Issue 4 | e1000730Network Modeling of microRNA Function in Cancer
PLoS Computational Biology | www.ploscompbiol.org 6 April 2010 | Volume 6 | Issue 4 | e1000730[39] and ITGB4 [40] is associated with cancer metastasis and/or
poor prognosis. Therefore, we evaluated the role of miR-204 in
HNSCC tumor progression. For these studies, we selected JSQ3
and SQ38 HNSCC cell lines for in vitro and SQ38 for in vivo
characterization. The two cell lines were derived from nasal cavity
and sinus HNSCC tumors, respectively (Table 5 in Text S2) [26].
In vitro, ectopic restoration of miR-204 function by miR-204
mimics had no effect on the viability and proliferation of the two
cell lines (Supporting Figure 6 in Text S1). In contrast, increased
miR-204 function led to a significant inhibition (P,0.05) of the
ability of JSQ3 and SQ38 cells to adhere to laminin-rich basement
membrane (Figure 4A), to migrate through porous Transwell
(Figure 4B), and to invade through Matrigel-coated basement
membrane (Figure 4C). These results demonstrate that increased
miR-204 function via its synthetic mimics is sufficient to suppress
cell-matrix interaction, motility and invasiveness in vitro.
To assess whether miR-204 could inhibit HNSCC tumor
metastasis in vivo, we increased miR-204 function in SQ38 with
miR-204 mimics treatments for three days prior to tumor
transplantation. We employed an experimental model of lung
metastasis by tail vein injection of tumor cells allowing
characterization of tumor cell extravasation and colonization in
the lung. For conducting in vivo fluorescent imaging analysis, we
generated SQ38 cells stably expressing high levels of GFP
fluorescent protein (Materials and Methods). To initiate the study,
one million of GFP-SQ38 cells transfected with either control
mimics or miR-204 mimics were transplanted into athymic mice
via tail-vein injection. GFP-SQ38 micrometastatic foci developed
in the lung over a period of three weeks were scored lobe by lobe
for each freshly isolated lung under fluorescent stereoscope
(Materials and Methods). Control mimics-treated SQ38 cells
efficiently extravasated, established micro-metastases in 100% of
animals and produced a mean number of lung metastatic foci of
75 on the whole lung surface. In drastic contrast, 50% of animals
(7 out of 14) receiving miR-204 mimics treated SQ38 cells failed to
develop any lung metastasis (Figure 4D–E and not shown), while
the other 50% of animals developed significantly less GFP-SQ38
lung foci at this early three-week time point (P=0.011 Figure 4E).
Moreover, consistent with the predicted role of miR-204 targets
AURKB and CDC25B as hub/bottleneck regulators of the cell
cycle sub-network (Figure 3), restoration of miR-204 function in
vivo significantly decreased the number of Ki-67 positive
proliferating single SQ38 cells (indicated by *) and micro-foci
(indicated by arrows) in the paraffin embedded lung sections
(P=0.001, Figure 4F). Moreover, Ki-67 positive SQ38 cells that
received miR-204 mimics treatment were mostly single-cell foci
and were in striking contrast to the multi-cell foci observed in the
lungs of control mimics treatment group (Figure 4F). Taken
together, these observations indicate that miR-204 can signifi-
cantly suppress experimental lung metastasis of SQ38 HNSCC
tumors, thereby acting as a potent suppressor of metastasis.
The novelty of our illustration of metastatic suppressor functions
of miR-204 in head and neck cancer and its relevance to
metastasis stems from our demonstration of miR-204 function at
multiple scales of biology that collectively show its potential as a
key regulator microRNA. Definitive demonstration of the role of
miR-204 in head and neck progression requires future studies
using cohorts of head and neck tumors.
Expression pattern of 19 miR-204 targets identified a
subtype of HNSCC tumors exhibiting an EGFR-pathway
signature and predicted earlier relapse
To explore the clinical relevance of miR-204 down regulation in
HNSCC, we conducted an unbiased hierarchical clustering
analysis of 60 HNSCC tumors harvested from representative
anatomical sites of HNSCC in GSE686 [41] based on the mRNA
expression pattern of 34 miR-204 targets identified in GSE6631
[21] (Materials and Methods). The original study reported a 582-
gene signature set in GSE686 that classified this set of tumors into
four distinct groups: (1) an EGFR-pathway signature subtype, (2) a
mesenchymal-enriched subtype, (3) a normal epithelial-like
subtype, and (4) a subtype with a high level of antioxidant
enzymes [41]. Hierarchical clustering using 19-upregulated genes,
a subset of miR-204 targets that could be mapped to this dataset,
identified two clusters (Figure 5). Tumors in Cluster A were
enriched with the EGFR signature and correspond to Group 1 of
the classification of Chung et al. (P,0.0001). In comparison,
tumors in Cluster B were enriched with the Group 3 ‘‘normal
epithelium-like subtype’’ tumors (P,0.011) [41]. This is consistent
with our observation that miR-204 targets were hub-bottleneck
regulators of an EGFR-dependent regulatory network in HNSCC
(Figure 3). Further, consistent with the prognostic capability of a
582-gene signature set reported by Chung et al. [41], Cluster A
showed overall earlier relapse than Cluster B (Figure S7). The fact
that very comparable prognostic predictions can be derived using
only 19 miR-204 gene targets suggest a potentially important role
of miR-204 in HNSCC prognosis and merits further investigation
and validation using a larger cohort of HNSCC tumor samples
with well-characterized clinical outcomes.
Discussion
Here, we developed an efficient combined computational and
biological approach to predict and to prioritize cancer microRNAs
for biological investigation. We demonstrated this strategy as an
effective economical alternative to comprehensive microRNA
analysis in cancers such as HNSCC for which prior genomic array
datasets (mRNA or microRNA) are less abundant. This approach
also allowed the identification of functional gene targets of the
deregulated microRNAs that would otherwise require paired
profiling of mRNA and microRNA expression for which the
feasibility is often limited by the additional costs, or by the lack of
access to the tissue. Employing this method that integrates the
analysis of microRNA target predictions, differential HNSCC
gene expression and the cancer genes in the OMIM genetic
dataset, we identified and characterized miR-204, located within
its host gene TRPM3 at the 9q21.1–q22.3 region frequently
incurring allelic loss [11–15], as a potential tumor suppressor
Figure 2. Predicted targets of miR-204 in HNSCC are significantly related via their molecular or biological functions. (A) Enrichment
of 34 miR-204 gene targets between 382 differentially upregulated HNSCC genes (GSE6631) and 1088 putative miR-204 targets predicted by
sequence-based microRNA target prediction databases (miRNOME); (B–C) Determination of mRNA expression of ‘‘functionally prioritized miR-204
targets’’ in four laser-microdissected HNSCC tumor samples (B) and in 10 HNSCC cell lines (C) by qPCR as described above in Figure 1 and in Materials
and Methods). Five equally pooled normal buccal mucosa RNAs were used as the normal control. Legend: red line (RQ=1) is the expression of the
TBP endogenous gene control; error bars represent standard error of the mean; shaded squares in the GO table indicate gene targets in the
corresponding ‘‘biological processes’’ (BP) and ‘‘molecular functions’’ (MF) of Gene Ontology (GO); adjusted P-values indicate the combined statistical
enrichment of these genes in GO (Materials and Methods). (D) Ectopic enhancement of miR-204 function inhibited its predicted gene targets mRNA
expression in JSQ3 HNSCC cell line. TBP expression was used as an endogenous gene control for normalization (red line) in the qPCR analysis.
doi:10.1371/journal.pcbi.1000730.g002
Network Modeling of microRNA Function in Cancer
PLoS Computational Biology | www.ploscompbiol.org 7 April 2010 | Volume 6 | Issue 4 | e1000730Figure 3. miR-204 gene targets exhibit significant topological properties in a predicted protein interaction network of HNSCC based on
single protein network modeling. (A–B) A 56-gene ‘‘prioritized HNSCC PPIN’’ was predicted from single protein network modeling and was
significantly enriched with bottleneck (P=7.3 610
27), hub (P=8.7 610
28) and hub-bottleneck genes (P=1.6 610
28). P-values were calculated using one-
tailed cumulative hypergeometric tests. Genes colored in red: miR-204 gene targets. (C) Gene Ontology enrichment analysis of the ‘‘biological processes’’
(BP)and‘‘molecularfunctions’’(MF)identifiedtwoEGFR-dependentsub-networksinthe‘‘prioritizedHNSCCPPIN’’(adjustedP,0.05). Different BPs and MFs
were coded by colors as indicated. Every gene analyzed in the network are represented as circles, the majority do not reach statistical significance and
remain as unnamed grey dots on the bottom of the figure (statistical details and names are provided in Table S11, and their interactions in Table S12).
doi:10.1371/journal.pcbi.1000730.g003
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enhancement of miR-204 function inhibited JSQ3 and SQ38 adhesion to laminaI or basement membrane complex (BMC) (A), migration through the
porous membrane in Transwell (B), and invasion through Matrigel (C). Triplicate repeats were conducted at experimental point for A (Methods). For
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The high propensity of LOH at 9q21.1–q22.3 that occurs in 37%
HNSCC pre-malignant conditions, further increases to 67% in
cancer state [14] suggesting the presence of tumor suppressor gene
candidates. While tumor suppressor genes at other frequent allelic
loss loci in HNSCC have been identified, gene candidates
responsible for the tumor suppressor activity associated with the
9q21 locus remain elusive. Here, we provided a plausible
mechanism that loss of tumor suppressor function of miR-204 as
a result of allelic imbalance at 9q21.1–q22.3 may significantly
increases the genetic susceptibility to HNSCC oncogenesis and
progression. LOH at this locus is also seen in the squamous cell
carcinoma (SCC) of the esophagus [42] and SCC of the lung [43]
suggesting a common somatic genetic lesion underlies the
development of SCC of diverse tissue origin. The highly
coordinated and nearly complete suppression of miR-204 and its
host gene TRPM3 (Figure 1B–E) raises the possibility that
TRPM3 mRNA expression may serve as a marker to indicate
miR-204 expression status in HNSCC or other tumors, and also
potentially LOH at 9q21.1–q22.3. Since a small variation in the
expression of a specific microRNA is expected to affect the
expression of tens or hundreds of target mRNAs, genetic
variations in a microRNA expression at the chromosomal break
point, as we observed with miR-204 at the 9q21.1–q22.3 locus,
could represent an effective mechanism of cancer predisposition, a
hypothesis that is supported by emerging experimental evidences
[44,45]. A few recent studies have reported genome-wide
microRNA expression changes using HNSCC cancer cell lines
[46–49] or tumor tissues [49–51]. While similar miR-204 down-
regualtion was reported in head and neck cancer cell lines based
on microarray analysis [46,48], its expression status was not
further confirmed by PCR or other methods and its biological
functions were not explored. Additionally, since its identification
[24] biological characterization of miR-204 functions in normal
development remain limited. Thus far, miR-204 was implicated in
affecting global mRNA expression levels in the retina [52]; and
was shown to regulate mesenchymal progenitor cell differentiation
[53].
B and C, cells migrated to the basal side of the porous membrane was visualized with a Zeiss Axiovert microscope at620 magnification. 10 random
fields from three replicate wells were counted and the number of cells that had migrated or invaded was presented as number of cells counted per
field of the porous membrane (Materials and Methods). Error bars represent mean6standard error of the mean (SEM); P-values were obtained using a
one-tail t-test with unequal variance. (D–E) Restoration of miR-204 function by miR-204 mimics treatment significantly attenuated GFP-SQ38 tumor
lung colonization. Total number of GFP-SQ38 lung surface foci was counted lobe by lobe using a Leica fluorescent stereoscope under 46
magnification [D(i) and E(iii)] in a total of 28 mice. A magnified view (86) of the insert in E(i) is shown in D(ii) (top). Scale bar: 100 mm, Error bars
represent mean6SEM. (F) Restoration of miR-204 function significantly decreased Ki-67 positive SQ38 cells in the lung. Ki-67 positive cells in each
section were counted in 10 randomly chosen fields (406) and six specimens in each experimental group were used (left panel). Error bars represent
mean 6 SEM; In (E) and (F), P-values were calculated based on unpaired one-tailed Mann-Whitney test. The image is a representation of a
microscopic field (right panel). * indicates single-cell GFP-SQ38 foci; arrows indicate multi-cell GFP-SQ38 foci.
doi:10.1371/journal.pcbi.1000730.g004
Figure 5. Expression pattern of miR-204 targets identified a subtype of HNSCC tumors exhibiting an EGFR-pathway signature and
miR-204 was deregulated in other squamous and epithelial tumors. miR-204 functional targets classified 60 HNSCC tumors in (GSE686) [41]
microarray based on their intrinsic properties (Methods). P-values were obtained using a Fisher’s exact test; *: censored data.
doi:10.1371/journal.pcbi.1000730.g005
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mRNA gene expression profile, we identified a set of functionally
related miR-204 targets that showed increased mRNA expression
in HNSCC upon miR-204 suppression (Figures 2A–C). The
presence of miR-204 binding sites (Table 8 in Text S2), the
coordinated up-regulation and the ability of increased miR-204
function to specifically inhibit the expression of 18 out of 21 gene
targets (86%) (Figure 2D, Supporting Figures 4–5 in Text S1)
suggest that these predicted genes are very likely selective and
direct miR-204 targets in HNSCC. This finding is consistent with
the genome-wide association between microRNA binding sites
and the ability of corresponding targeting microRNAs to alter
their gene expression [54]. This is the first report of a large set of
functionally related cancer microRNA targets that was identified
via high throughput computational approaches and confirmed
biologically. In addition, the joint analyses of sequence-base
information and mRNA expression arrays yielded an accuracy
rate of 86% of miR-204 target predictions which surpasses the
published accuracy (about 40%) of each sequence-based method
when used alone [10,55,56].
More broadly, we demonstrated a computational framework for
predicting altered regulatory networks and biological functions
associated with differentially expressed microRNA targets. Indeed,
our combined systems biology approach uncovered previously
unknown connections between microRNA regulation, network
topology, and expression dynamics for which we obtained
thorough biological validations. While genome-scale analyses of
interactions among microRNA gene targets in the context of a
cellular or protein-protein interaction networks have been
conducted computationally [57–59], such methods and observa-
tions await biological confirmation. Here we significantly extended
the observations of two recent reports on network modeling
[31,32] and demonstrated the feasibility and validity of deploying
statistical and bioinformatics approaches to derive regulatory
networks corresponding to altered expression of proteins targeted
by microRNAs (Figure 3). Further, combining functional enrich-
ment analysis with network modeling leads to the unbiased
prioritization of an EGFR-dependent protein regulatory network
connected via up-regulated gene targets of microRNAs in human
HNSCC (Figure 3C). Topological analyses of hub and bottleneck
properties further identified key regulatory proteins within the
EGFR network (Figures 3A–B). miR-204 appeared critical to
regulate the function of this ‘‘prioritized HNSCC PPIN’’ as its
gene targets exhibited significant enrichment of hub and
bottleneck properties (Figures 3A–B). Since the EGFR network
was derived from overexpressed genes in HNSCC, the functional
enrichment of its 56 proteins suggests their positive regulation of
cell cycle, cell/matrix adhesion and extracellular matrix modeling.
Using this approach, the biological effect of altering the function of
a specific microRNA, such as miR-204, can be accurately
predicted via its gene targets that are key regulators of a protein
network. Accordingly, enhancement of miR-204 function inhib-
ited the expression of its functionally related gene targets (Figure
2D, Supporting Figures 4–5 in Text S1) in the ‘‘prioritized
HNSCC PPIN’’ and lead to the reduced adhesion, migration and
invasion in vitro (Figures 4A–C) and experimental lung metastasis in
vivo (Figures 4D–F). Further, the strong association of overexpres-
sion of functional miR-204 gene targets with an earlier relapse in a
sub-type of HNSCC tumors expressing an EGFR-pathway
signature (Figure 5) suggests that miR-204 expression and its
deregulated gene targets could be potentially used for mechanism-
based prognostic stratification of HNSCC patients to complement
the conventional clinical-pathological tumor diagnosis. In fact, the
feasibility of employing microRNA as sensitive and informative
biomarkers for molecular diagnosis has recently been demonstrat-
ed [60].
Collectively, these findings show that single protein network
modeling and statistical functional enrichment of a PPIN can
illuminate altered complex biological processes and regulatory
pathways associated with microRNA dysfunction in cancer with
high precision. Complementary approaches have been developed
to analyze gene expression changes in the molecular and biological
context for candidate gene prioritization and for deriving
mechanistic understandings that are most relevant to cancer
biology [61–64]. The system’s properties and microRNA-regulat-
ed molecular networks we discovered could be exploited for the
design of ‘‘network mechanism’’-based therapies to specifically
restore tumor suppressor microRNA functions as an alternative to
the single-gene target paradigm and merits further investigation.
Materials and Methods
Ethics statement
All animal works have been conducted according to IACUC
guidelines and were approved at the IACUC committee at the
University of Chicago. All research involving human participants
have been approved by the authors’ institutional review board.
Informed consent has been obtained.
Gene expression analysis of microarray data and
subsequent statistical analyses (Figure 1A, Figure 1G,
Figure 5 and Supporting Figure 3 in Text S1)
Microarray datasets were downloaded from NCBI GEO
database. The .cel file of HNSCC mRNA transcription array sets
GSE6631 [21] and GSE2379 [22] were processed using the
Bioconductor Package [65] implementation of GCRMA in R
Software [66]. To identify differentially expressed genes, SAM
analysis [67] was performed using paired T-test between the
HNSCC tumor and its corresponding paired normal tissue
obtained from the same patient. The criteria for gene selection
were fold change $2 and False Discovery Rate (FDR) #0.0006
(Figure1A and Supporting Figure 3 in Text S1).
The association of miR-204 targets with clinical parameters was
analyzed using HNSCC mRNA array set GSE686 [41]. The
intensity ratios of red to green channel of the predicted miR204
targets were retrieved from GSE686 dataset. Missing values were
assigned a constant value of 0. Redundant probes representing an
identical gene were reduced to a single one using the mean
expression value. The miR-204 targets predicted in Figure 2A and
filtered by coefficient of variation .0.3 were used for hierarchical
clustering. In Figure 5, the two-way hierarchical clustering was
conducted with the dChip software using its default parameters
(distance metric: 1-Pearson correlation; centroid linkage clustering)
[68], while the significance of the association between the
hierarchical clusters and molecular groups of HNSCC samples
[41] was determined by two-tailed Fisher’s exact test adjusted with
Bonferroni correction. The sample information file was obtained
from the Table S1 of Chung et al [41]. The time to recurrence
(termed relapse time), shown in Supporting Figure 7 in Text S1,
was analyzed with the Kaplan-Myer method using the Logrank
test of GraphPad Prism software (version 4) [69], and right
censoring was conducted for subjects alive at the end of the study
(subjects identified by ‘‘*’’ in Figure 5).
To determine the miR-204 expression status in epithelial
tumors (Figure 1G), the expression values of miR-204 were
extracted from microRNA array set GSE2564 [18]. Only six solid
tumor types, colon, kidney, prostate, uterus, lung and breast that
contained more than one samples in both tumor and the respective
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tumors and their respective normal tissues were performed by
unpaired two-tail t-test with unequal variances.
Prediction of HNSCC down-regulated microRNAs from
public gene expression profiles and putative microRNA
target genes (Table 1 in Text S2, Table 9 in Text S2)
Generation of an integrated human microRNA target
database-miRNOME. We generated an integrated and com-
prehensive human microRNA target database, ‘‘miRNOME’’, by
merging five microRNA target datasets: TargetScan [10],
PicTar4way [70], miRBase [56], miRanda [55] and TarBase
[71] (integration details provided in Table 9 in Text S2). Down-
loaded versions are described in Table 1 in Text S2. miRNOME
contains 534 distinct human microRNAs, 17,343 predicted
putative microRNA gene targets and 444,558 distinct
microRNA-Target relationships. Specifically, 5110 distinct genes
in GSE6631 and 5131 distinct genes in GSE2379 are respectively
targeted by 531 and 530 microRNAs in the miRNOME.
Imputed microRNA regulation based on weighted ranked
expression and putative microRNA targets (IMRE) (Figure
1A, Supporting Figure 2 in Text S1, and Table 2 in Text
S2). We developed a novel prioritization method (Supporting
Figure 2 in Text S1) to predict microRNA regulation from
genome-wide gene expression and microRNA putative targets
predicted by the miRNOME database. Using the expression of
putative targets of microRNAs in miRNOME, we calculate a P-
value for each microRNA representing their potential deregulation
between the cancer and normal tissue conditions. The method
development and procedures for conducting IMRE analysis are
detailed below:
Filtering. After GCRMA normalization, about half the genes
were filtered out according to the following criteria: i) probes
whose average expression intensity are below the average
background intensity, or ii) the probes whose inter quartile range
(IQR) are lower than the median of the rest probe-set’s IQR
because they are less likely to be differentially expressed, and/or
iii) to control for the bias of multiple probes per gene, the probe-
sets with the largest IQR value were retained and the others were
removed for the genes with multiple probe-sets.
Expression processing. In sample j containing a total of G genes,
each gene x is ranked by expression as rx,j M {1, 2…G}, and scored
according to an exponential weighted Sx,j (Equation 1) using an
approach that we previously described to compare gene expression
lists (OrderedList [72] method of Bioconductor [73]).
Sx,j~ rx,j
  
| e
rx,j
G
  
ð1Þ
Prediction of microRNA target regulation. The contribution of a
microRNA mi regulation of gene expression to a single sample j is
imputed by calculating the difference between the centroid of
weighted rank expression (WRE) of its targets according to the
miRNOME (CTi,j, Equation 2) with that of non-targeted genes
(CNi,j, Equation 2), referred to as DCWRE (Equation 3); where Ti,j
is the target gene-set of microRNA (mi), and Ni,j is the non-target
gene-set of this microRNA. Further, the scores are adjusted for the
cardinality (count of genes) of each gene-set (e.g. cardinality of Ti,j
is | Ti,j |; Equation 3). DCWRE follows a normal distribution in
both GSE6631 and GSE2379 (data not shown). An empirical
Student T-test for unequal variances was performed to compare
DCWREi for each microRNA mi between cancer and normal tissue
(Bioconductor package twilight, 1,000 permutation resampling,
‘‘paired t-test’’for GSE6631, ‘‘unpaired t-test’’ for GSE2379 [74]).
To adjust for multiple comparisons (different microRNAs on the
same dataset), we calculate a Benjamini and Hochberg false
discovery rate (FDR) from the P-values of Equation 4 and used a
5% threshold for significance [75]. The IMRE algorithm written
in R language and bioconductor is made available at http://www.
lussierlab.org/IMRE.
CTi,j~
1
DTi,jD
X
x[Ti,j
(Sx,j) and CNi,j~
1
DNi,jD
X
x[Ni,j
(Sx,j)ð2Þ
DCWREi~CTi,j{CNi,j ð3Þ
Prediction of microRNAs deregulated in cancers from
enrichment analysis of inheritable cancer genes in OMIM
(Figure 1A, and Table 3 in Text S2)
MicroRNAs most likely to regulate a large number of specific
inheritable cancer genes were predicted using an enrichment
statistics. The Online Mendelian Inheritance in Man (OMIM)
[76] is a semistructure database in which we computationally
coded cancer genes (OncoMIM, Protocol S1/Section A) to a
clinical nomenclature and mined with statistical enrichment to
predict microRNAs that could deregulate a large number of genes,
each associated with a certain type of cancer. OncoMIM contains
610 biologically validated or clinically demonstrated inheritable
cancer genes among which 586 (96%) are predicted targets of 527
microRNAs in the miRNOME, from which we can calculate
significantly enriched microRNAs.
The cumulative hypergeometric distribution (Equation 4) was
applied to identify significantly enriched microRNAs. We
calculated the P-values based on the Equation 4 with the
following variables: N is the number of OMIM genes also found
in the miRNOME (3232 for anatomy, 2181 for disease), M is the
number of genes associated to a specific cancer term in OncoMIM
and also targeted by any microRNAs in the miRNOME, n
represents the number of genes targeted by a specific microRNA
in the miRNOME and also found in OncoMIM associated to any
cancer term, m is the number of genes associated to both a specific
cancer term in OncoMIM and to a specific microRNA in the
miRNOME (m=M>n).
p(iw~mDN,M,n,m)~
X n
i~m
M
i
  
N{M
n{i
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To control p in Equation 4 for multiple comparisons, we
applied the Bonferroni-type adjustment method known as S ˇida ´k
single-step adjusted P-value for multiple comparisons (Equation 5)
[77]. Significant correlations are first refined to remove false
positive signals inherited in the hierarchies of the clinical
nomenclature (Protocol S1/Section B) and then adjusted P-values
(p9) are less than 0.05 (n=number of comparisons, p taken from
Equation 4)
p’~1{(1{p)
n ð5Þ
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GO or of SNOMED terms (Supporting Figure 8 in Text S1,
Protocol S1/Section B)
We developed an algorithm to identify and filter out false
positive P-values derived from enrichment studies in ontologies
(hierarchical classifications) due to the inheritance of genes in
ancestry classes of a significantly enriched class [78,79] (Support-
ing Figure 8 in Text S1, Protocol S1/ection B).
Review of literature of deregulated microRNA in cancer
(Supporting Figure 3 in Text S1, Table 4 in Text S2)
A gold standard of microRNAs deregulated in cancers was
derived from the literature and was used to evaluate microRNA
predictions in from OMIM cancer genes (Supporting Figure 3 in
Text S1).
Prioritized HNSCC PPIN using Single Protein Network
Modeling in a protein-protein interaction network
(Figure 3 and Tables 10–12 in Text S2)
Datasets used to construct the protein-protein interaction
network (Figure 3, Table 10 in Text S2, Protocol S1/Section
D). The protein-protein interaction network (PPIN) was
generated by integrating seven protein interactions and signaling
datasets. Protein interactions from each dataset were standardized
to a two-column list of pair wise interactions between SwissProt
accession IDs, with an additional column providing the source
dataset and references to the literature when available. An
overview of the seven datasets used in this study is provided in
Table 10 in Text S2, while the details of the integration process is
provided in Protocol S1/Section D.
Generation of protein-protein interaction network.
Homo sapiens data was retained from BIND, BioGRID, DIP,
HPRD, KEGG, MINT, and Reactome. Postulated interactions in
Homo sapiens based on Yeast Two-Hybrid experiments were
excluded. Identifiers were converted to a common SwissProt
standard coding using translation tables from HGNC (Table 9 in
Text S2) and the data sources’ own cross-mappings.
Conservative permutation re-sampling of the
PPIN. Permuted PPIN networks were generated using a link
randomization approach [80]. Proteins are considered as nodes,
and interactions between proteins are links. Since biological
networks are scale free rather than random [81,82], link-
randomization can create conservative ‘‘permuted networks’’ as
controls, from which we can derive an empirical distribution of
interactions between a subset of proteins. Furthermore, our
implementation of a link-randomization conserves the number of
‘‘connections’’ of each protein (node-degree [81–83]). Thus the
scale free properties of the original distribution are preserved in
every permutation as well as the node degree of each specific
protein, while the interactions (links) between these proteins vary.
Self- interactions, such as those formed by homomultimers, were
ignored to avoid introducing bias into the network. Duplicate
protein interaction pairs were also excluded in the permutation.
10,000 of these permuted networks were generated from the
original amalgamated interaction network consisting of real
datasets.
Single Protein Network Modeling and Prioritized HNSCC
PPIN (Figure 3 and Tables 11–12 in Text S2). Additionally,
we developed a model that estimates the probability of occurrence
of an observed Single Protein Network arising from the
upregulated gene list between HNSCC and normal paired tissue
in GSE6631. Each of these unregulated HNSCC gene was
translated to its corresponding protein identifier in the network
(HNSCC protein). Each HNSCC protein was mapped to each of
the rest HNSCC proteins according to existing pairs of protein
interactions in the original PPIN yielding an Observed number of
distinct Protein Interactions (Observed count of PI). Thereafter,
the same procedure was applied to the 10,000 permuted PPINs
yielding control counts of distinct protein interactions for each of
the UG (Control count of PI). Since each HNSCC protein had a
constant node degree in each permutation (see the previous
paragraph), this procedure controlled properly for HNSCC
proteins having more protein interactions than others thus
providing no statistical advantage to those better connected
proteins (such as hub or bottleneck proteins). For each HNSCC
protein, a P-value was assigned by measuring the frequency at
which the ‘‘Observed count of PI’’ of that HNSCC protein
occurred in the empirical distribution of 10,000 ‘‘Control count of
PI’’ for these specific HNSCC proteins (Table 11 in Text S2).
Each HNSCC proteins were subsequently ranked according to its
P-value. At each cutoff P-value, a certain number of HNSCC
proteins were prioritized. Consequently, a FDR of the prioritized
HNSCC proteins (FDR of prioritized proteins) was calculated by
dividing the median number of proteins prioritized at that cutoff in
the empirical distributions of permuted PPINs divided by the
observed number of prioritized HNSCC proteins in the real PPIN.
We refer to this approach as single protein analysis in the network
(SPAN).
A similar procedure was developed to calculate the FDR over a
pair of protein interactors among the observed prioritized
HNSCC proteins (FDR of links). A ‘‘Prioritized HNSCC PPIN’’
(Figure 3) was predicted from SPAN in the ‘‘genome-scale PPIN’’
with a FDR of 7.14% for the links between labeled genes and of
10.15% for upregulated HNSCC genes in GSE6631. The
resulting network was drawn using Cytoscape [84]. Details on
the protein interaction dataset supporting each pair of protein
interactions are provided in Table 12 in Text S2. Hubs in the
PPIN are defined as the top 20% of proteins’ node degree (grey
nodes in Figure 3A). Similarly, the bottlenecks (grey nodes in
Figure 3B) are defined as proteins are the top 20% betweenness
score calculated using the ‘‘betweenness.c’’ program we developed
(http://www.gersteinlab.org/proj/bottleneck/) [30]. 10.4% of the
PPIN proteins were observed to have both hub and bottleneck
properties. Enrichment studies of hub, bottleneck and hub-
bottleneck proteins presented in Figure 3 have been conducted
using one-tailed cumulative hypergeometric distribution.
Enrichment of Hub and Bottleneck Proteins in the
HNSCC PPIN associated with microRNA targeting
(Figure 3A–B). To determine whether microRNA targets in
the HNSCC PPIN exhibit the genome-wide systems’ properties of
‘‘hub’’ and ‘‘bottleneck’’ and their enrichment, we calculated the
proportion of hub and of bottleneck proteins among microRNA
targets present in the HNSCC PPIN for each microRNAs in the
miRNOME. Thereafter, we conducted a non-parametric
Wilcoxon Signed Rank Test comparing this frequency with the
theoretic expectation that derives from a random draw (as defined
in the previous paragraph: 20%).
Using the miRNOME, we also calculated the number of
distinct microRNAs that could potentially target the genes
encoding for each protein of the PPIN. We subsequently obtained
enrichment statistics of the hub and bottleneck properties related
to microRNA regulation by comparing the count of microRNAs
between hub proteins and non-hub proteins, between bottleneck
and non-bottleneck proteins, as well as between hub-bottleneck
and non hub-bottleneck proteins using the non-parametric Mann
Whitney test. Calculations of these statistics were conducted with
the GraphPad Prism software (version 4) [69].
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PPIN using Gene Ontology (Figures 2B–C, Figure 3C,
Table 7 in Text S2, Protocol S1/Section C)
To provide insights into biological functions and processes
potentially regulated by miR-204 in HNSCC, we conducted
standard statistical enrichment analyses based on the functional
assignments of gene in Gene Ontology (GO) [28] to infer
significantly deregulated functions associated with altered miR 204
target expression in the HNSCC according to their presence in the
miRNOME and/or the PPINs (details in Protocol S1/Section C).
Generation of Head and neck cancer cell lines and cell
culture
We previously established 10 low passage human head and neck
squamous cell carcinoma lines (HNSCC) (SCC25, SCC35, SCC58,
SCC61, SCC135, SCC151, SQ20B, SQ38, and JSQ3), from head
and neck tumor specimens of different head and neck primary sites
[26]. This panel of cell lines was established from head and neck
tumor specimens of different primary sites and most of the patients
quickly developed local failure and eventually died of the disease
[26]. Nu61 was derived from SCC61 tumors that developed
radioresistance after serial passage and radiation treatment in vivo
[85]. All cell lines were cultured and maintained in 1:1 DME/F12
supplemented with high glucose and 10% fetal bovine serum. GFP-
SQ38 cells were established via retroviral-mediated gene transfer
using pLEGFP-N1 retroviral vector (Clontech).
Quantitative RT-PCR Analysis of microRNA and mRNA
expression (Figure 1B–F, Supporting Figures 4–6 in Text
S1, and Table 13 in Text S2)
Total RNA from normal and tumor tissues of esophagus, lung
and cervix were obtained from the Ambion FirstChoice collection
of RNA that is compatible with both mRNA and microRNA
analysis.
Total RNA from HNSCC cell lines, tumors and normal tissues
was extracted and purified using TRIzol (Gibco/BRL) according
to manufacturer’s instructions. Tissues from primary HNSCC
tumors were obtained from surgical procedures performed at our
institution. Samples were snap frozen immediately in liquid
nitrogen and stored at 280 uC. Laser micro-dissection was
performed on frozen sections and approximately 10,000 cells were
captured for RNA extraction. Normal buccal mucosa was
obtained from healthy volunteers with no history of smoking
and drinking according to an approved open IRB protocol.
miR-204 expression was measured using TaqMan MicroRNA
quantitative PCR (qPCR) assay (Applied Biosystems) according to
manufacturer’s instructions.. Real-time PCR was carried out using
the Applied Biosystems 7900 Sequence Detector System (Applied
Biosystems). All qPCR reactions were run in triplicate. Human
TATA-binding protein (TBP) (Applied Biosystems) was used as an
endogenous control for miR-204 expression normalization. The
fold changes of miR-204 expression between normal and tumor
tissues or cell lines were calculated using the DDCt method of
relative comparison.
For mRNA expression quantification, First-strand cDNA
synthesis was carried out as above described except that random
primers were used for reverse transcription (High Capacity cDNA
Reverse Transcription Kit, Cat#4368814). Amplification of
predicted miR-204 targeted genes was performed by Sybr Green
qPCR assays using custom designed primers. Specific primers for
each gene were designed using Invitrogen D-LUX Designer
(https://orf.invitrogen.com/lux/) and sequences provided in
Table 13 in Text S2. The mean Ct (cycle threshold) was
calculated from the triplicates and used for the calculation of RQ
values. qPCR condition for each gene was optimized that so that
the standard error among the triplicates was ,0.15 Ct. TBP was
also used as endogenous control for data normalization. The fold
changes of target gene were calculated using the DDCt method of
relative comparison. In addition, as negative controls for the off
target effect of miR-204 mimics treatment, real time qPCR was
performed to include three additional endogenous controls: PPIA
(AB, Cat#4333763), GUSB (AB, Cat# 4333767) and, HPRT1
(Cat#4333768) using commercially designed Taqman gene
expression assays (Applied Biosystems). Quantitative mRNA
expression data were acquired and analyzed in either 96- or
384-well-plate format using an Applied Biosystems 7900 Sequence
Detector System (Applied Biosystems).
Increase miR-204 function by miRIDIAN mimics
treatment (Figure 2D and Figure 4)
40% confluent JSQ3 and SQ38 cells were transfected with 50–
200 nM Control [Cat#110CN-001000-01] or miR-204 miRI-
DIAN mimics [Cat#110C-300069-02](Dharmacon) using Oligo-
fectamine (Invitrogen). Transfection efficiency was optimized and
estimated to be .90%. Proliferation assay, cell adhesion assay.
Migration assay and Matrigel invasion assay were conducted at
72 hours after transfection. In vivo tail-vein injection of mimics
treated GFP-SQ38 cells was performed at 48h after transfection.
InnoCyte ECM Cell adhesion assay (Figure 4A)
Cell adhesion was measured using the InnoCyte ECM cell
adhesion assay kit (Calbiochem, Cat#CBA025) according to
manufacturer’s instructions. Control or miR-204 miRIDIAN
mimics treated JSQ3 and SQ38 cells were trypsinized and re-
suspended in fully supplemented medium. 20,000 cells and 15,000
cells were added to each well for JSQ3 and SQ38 cell lines,
respectively. Cells were incubated for 2h at 37 uC. The plates were
thenwashedwithPBStoremovenon-adherentcells.100 mlCa lc ei n -
AMwasadded toeach well,incubatedwith cells for 1h at 37uC,and
read with a fluorescent plate reader at an excitation wavelength of
,485 nm and an emission wavelength ,520 nm. Results were
expressed as percent of cell adhesion compared to that of control
mimics treated controls6standard error (SE) of 3 replicates.
Trans-well migration and invasion assays (Figure 4B,C)
Control or miR-204 miRIDIAN mimics treated JSQ3 and
SQ38 cells were trypsinized and re-suspended in fully supple-
mented medium. Cells were then seeded at 10,000 cells per well
for migration assay or at 20,000 cells per well for invasion assay
into trans-well inserts (8 mm pore size, BD Falcon). For invasion
assay, the trans-well inserts were coated with 60 mg/45 ml/well of
Matrigel (BD Falcon). Complete culture medium was used as
chemo-attractant in the lower chamber. The assays were taken
down with three PBS washes followed by fixation with 10%
formalin and staining with 1% crystal violet after 6h for migration
assay and 18h for invasion assay. The cells migrated to the basal
side of the porous membrane was visualized with a Zeiss Axiovert
microscope at 620 magnification. 10 random fields from three
replicate wells were counted and the number of cells that had
migrated or invaded was presented as number of cells counted per
field of the porous membrane.
Determination of cell proliferation (Supporting Figure 6
in Text S1)
Cell proliferation assays were conducted in 96-well format by
the MTT assay. Specifically, HNSCC cell lines were seeded at
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3 cells/well in 96-well plates and let incubated for 24 hours
prior to treatment with control or miR-204 miRIDIAN mimics.
After drug or siRNA exposure, 10 ml of MTT reagent was added
to each well and incubated for 4h. The precipitates were dissolved
in 100 ml of stop solution overnight and proliferation rate was
determined by absorbance at 570 nm wavelengths with 690 nm as
the reference wavelength using a spectrophotometer.
Animal studies (Figure 4D)
Animal work was conducted in accordance with an approved
protocol. Age and weight-matched (4–6 weeks old weigh 18–20 g)
NCI athymic female mice were used for induction of experimental
lung metastasis via the tail-vein injection of tumor cells. GFP-
SQ38 cells were treated with miR-204 miRIDIAN mimics or non-
specific control mimics for 2 days prior to tumor cell inoculation.
1610
6 viable cells were re-suspended in 100 ml of PBS and
injected into the lateral tail vein. Metastatic colonization of lung by
GFP-SQ-38 cells was determined at 3 weeks post tumor injection.
Characterization and quantification of lung metastasis
(Figure 4E)
28 Mice were sacrificed on day 21 after tumor cell inoculation.
Lungs were perfused through tracheal with 2–3 ml of PBS, excised
and then fixed in 10% formalin for 12 hours. Prior to fixation with
formalin, lungs were examined under 46 magnification using
fluorescent stereoscope (Leica) and scored lobe by lobe for GFP-
SQ38 lung foci on the whole lung surface. Thereafter, the
University of Chicago Immunohistochemistry Core Facility
performed paraffin embedding, sectioning and H and E staining.
5-micron sections were stained with Ki-67 and Ki-67 positive SQ-
38 cells or micro-foci were scored under 406magnifications in 10
randomly selected fields for each section. A total of 6 lungs from
each treatment group were examined.
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